By Jonathan Gardner | Published October 8, 2026 In a move designed to fortify its position in...
Treatment Innovations
In a landmark development for pediatric neurology, Argus Cognitive has secured US Food and Drug Administration (FDA)...
The landscape of preclinical drug discovery is undergoing a profound metamorphosis. For decades, the life cycle of...
By Jonathan Gardner | Published October 8, 2026 In a move signaling a renewed focus on high-value,...
In the landscape of modern drug discovery, a quiet revolution is unfolding within the archives of pathology...
The Fall of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis
The Fall of a CRISPR Pioneer: Caribou Biosciences Seeks Strategic Alternatives Amid Financing Crisis
In a stark reminder of the volatile nature of the biotechnology sector, Caribou Biosciences—a CRISPR-focused firm co-founded...
In a landmark development for neurovascular medicine, California-based Sonorous Neurovascular has secured Investigational Device Exemption (IDE) approval...
In the traditional landscape of preclinical drug development, the journey of a tissue sample was linear and...
In a sobering turn of events for the biotechnology sector, Caribou Biosciences—a company anchored by the prestige...
In a significant move that promises to reshape the landscape of urological care, Zenflow, a California-based medical...
